Ameritas Advisory Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ameritas Advisory Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$1024.09 - $1201.76 $8,192 - $9,614	-8 Reduced 2.1%	373 $392,000
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $4,416 - $5,355	5 Added 1.33%	381 $400,000
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $28,886 - $31,787	-32 Reduced 7.84%	376 $361,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $97,672 - $111,094	126 Added 44.68%	408 $358,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $195,270 - $238,112	282 New	282 $232,000
Q1 2023 Apr 28, 2023	SELL	$680.49 - $826.97 $16,331 - $19,847	-24 Reduced 8.22%	268 $220,000
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $4,235 - $4,598	-6 Reduced 2.01%	292 $210,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $171,043 - $215,847	298 New	298 $205,000
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $228,113 - $307,357	-416 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$595.12 - $698.43 $51,180 - $60,064	86 Added 26.06%	416 $291,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $179,348 - $221,420	330 New	330 $208,000

1,485

84.8M

1.51M

1.48M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Ameritas Advisory Services, LLC with notifications on news.